药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halothane
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Acetyldigoxin.
Halothane
Lorajmine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Lorajmine.
Halothane
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Oxolinic acid.
Halothane
Prajmaline
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Prajmaline.
Halothane
Cibenzoline
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Cibenzoline.
Halothane
Pilsicainide
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Pilsicainide.
Halothane
Givinostat
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Givinostat.
Halothane
Temefos
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Temefos.
Halothane
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Prulifloxacin.
Halothane
CUDC-907
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with CUDC-907.
Halothane
Anisodamine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Anisodamine.
Halothane
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Pazufloxacin.
Halothane
Talinolol
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Talinolol.
Halothane
Bilastine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bilastine.
Halothane
Difloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Difloxacin.
Halothane
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Sarafloxacin.
Halothane
Phosmet
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Phosmet.
Halothane
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Orbifloxacin.
Halothane
Fenthion
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Fenthion.
Halothane
Famphur
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Famphur.